Drug Reaction with Eosinophilia and Systemic Symptoms Associated with a Vancomycin-Impregnated Spacer

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe adverse drug reaction with a mortality rate near 10% characterized by erythematous cutaneous eruption, multiorgan involvement, and hypereosinophilia. This case report highlights a patient who developed DRESS in the setting of intravenous vancomycin and a vancomycin and tobramycin-impregnated (PROSTALAC, DePuy Synthes, Warsaw, IN) functional spacer. The spacer was placed during the revision of a left total knee replacement complicated by a septic joint. To our knowledge, this is the third reported case of DRESS associated with vancomycin-impregnated spacers. As DRESS is a potentially life-threatening reaction and the principal treatment is withdrawal of the precipitating drug, it is important to consider this clinical entity and discontinue all forms of the causative agent. Patients with DRESS may develop a diffuse cutaneous eruption, respiratory failure, acute kidney injury, elevated liver enzymes, lymphadenopathy, and/or hemodynamic instability following intravenous infusion of antibiotics or placement of antibiotic-impregnated spacers, beads, or bone cement. Interestingly, this patient had a prominent and progressive erythematous eruption surrounding the left knee that improved after operative removal of the spacer. At 6 week hospital follow-up, the patient's systemic signs and symptoms had essentially resolved.

Keywords

vancomycin - antibiotic spacer - rash - DRESS syndrome

• References

• 1 Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011; 36 (1) 6-11
• 2 Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15 (4) 250-257
• 3 Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146 (12) 1373-1379
• 4 Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002; 8 (1) 5
• 5 Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206 (4) 353-356
• 6 Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55 (1) 1-8
• 7 Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect Dis 2010; 10: 49
• 8 Neuman MG, McKinney KK, Nanau RM , et al. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation. Transl Res 2013; 161 (5) 430-440
• 9 Ghanem E, Parvizi J, Burnett RS , et al. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am 2008; 90 (8) 1637-1643
• 10 Paradowski PT, Bergman S, Sundén-Lundius A, Lohmander LS, Roos EM. Knee complaints vary with age and gender in the adult population. Population-based reference data for the Knee injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoskelet Disord 2006; 7: 38
• 11 Díaz-Mancebo R, Costero-Fernández O, Vega-Cabrera C , et al. Dress syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactams. Case report and literature review. Nefrologia 2012; 32 (5) 685-687
• 12 Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol 2005; 64 (2) 155-158
• 13 Yazganoglu KD, Ozkaya E, Ergin-Ozcan P, Cakar N. Vancomycin-induced drug hypersensitivity syndrome. J Eur Acad Dermatol Venereol 2005; 19 (5) 648-650
• 14 Kwon HS, Chang YS, Jeong YY , et al. A case of hypersensitivity syndrome to both vancomycin and teicoplanin. J Korean Med Sci 2006; 21 (6) 1108-1110
• 15 Tamagawa-Mineoka R, Katoh N, Nara T, Nishimura Y, Yamamoto S, Kishimoto S. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. Int J Dermatol 2007; 46 (6) 654-655
• 16 Vauthey L, Uçkay I, Abrassart S , et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology 2008; 82 (2) 138-141
• 17 O'Meara P, Borici-Mazi R, Morton AR, Ellis AK. DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. Allergy Asthma Clin Immunol 2011; 7: 16
• 18 Schnetzke U, Bossert T, Scholl S, Freesmeyer M, Hochhaus A, La Rosée P. Drug-induced lymphadenopathy with eosinophilia and renal failure mimicking lymphoma disease: dramatic onset of DRESS syndrome associated with antibiotic treatment. Ann Hematol 2011; 90 (11) 1353-1355
• 19 Cariou ME, Kaabar M, Cailliez P , et al. Vancomycin-induced DRESS syndrome: a case report [in French]. Ann Biol Clin (Paris) 2013; 71 (2) 190-195
• 20 Azubike E, Akhil V, Margaret W , et al. Vancomycin induced DRESS syndrome: An unusual cause of life threatening stridor and bronchoconstriction. Am Thor Soc 2010; A3081
• 21 Song EK, Seon JK, Jeong MS. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement. J Bone Joint Surg Br 2010; 92 (11) 1596-1599
• 22 Bajaj P, Prematta MJ, Ghaffari G. A sixty-five-year-old man with rash, fever, and generalized weakness. Allergy Asthma Proc 2011; 32 (1) e1-e3
• 23 Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol 2013; 27 (6) 722-726
• 24 Um SJ, Lee SK, Kim YH , et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 2010; 20 (7) 556-562
• 25 Davern TJ. Drug-induced liver disease. Clin Liver Dis 2012; 16 (2) 231-245
• 26 Cacoub P, Musette P, Descamps V , et al. The DRESS syndrome: a literature review. Am J Med 2011; 124 (7) 588-597
• 27 Berbari EF, Hanssen AD, Duffy MC , et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27 (5) 1247-1254
• 28 Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 1998; 13 (3) 331-338
• 29 Williams B, Hanson A, Sha B. Diffuse Desquamating Rash Following Exposure to Vancomycin-Impregnated Bone Cement. Ann Pharmacother 2014; 48 (8) 1061-1065
• 30 Park HB, Choi JS, Park SH, Kee WJ, Koh YI. Drug fever due to piperacillin/tazobactam loaded into bone cement. J Korean Med Sci 2011; 26 (2) 301-303
• 31 Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006; 40 (11) 2037-2042
• 32 McGlothan KR, Gosmanova EO. A case report of acute interstitial nephritis associated with antibiotic-impregnated orthopedic bone-cement spacer. Tenn Med 2012; 105 (9) 37-40 , 42